Cargando…

Radiocontrast Media: Applications and Concerns

Detalles Bibliográficos
Autores principales:	Mahajan, Rajiv, Singh, Pushpinder
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822330/ https://www.ncbi.nlm.nih.gov/pubmed/31681540 http://dx.doi.org/10.4103/ijabmr.IJABMR_322_19

Ejemplares similares

Radiocontrast Media Hypersensitivity Reactions in Children
por: Saretta, Francesca, et al.
Publicado: (2022)

Radiocontrast media hypersensitivity in the Asia Pacific region
por: Lee, Suh-Young, et al.
Publicado: (2014)

The efficacy of single premedication with antihistamines for radiocontrast media hypersensitivity
por: Lee, So-Hee, et al.
Publicado: (2016)

Molecular Mechanisms of Renal Cellular Nephrotoxicity due to Radiocontrast Media
por: Michael, Ashour, et al.
Publicado: (2014)

Radiocontrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease
por: Jo, Sang-Kyung
Publicado: (2012)

Effectiveness of premedication for hypersensitivity reactions to radiocontrast media in one tertiary hospital
por: Jung, JaeWoo, et al.
Publicado: (2014)

Successful desensitization to radiocontrast media in two high-risk cardiac patients
por: Al-Ahmad, Mona, et al.
Publicado: (2017)

Electronic Consultation Support System for Radiocontrast Media Hypersensitivity Changes Clinicians' Behavior
por: Yang, Min-Suk, et al.
Publicado: (2018)

The Effectiveness of Automatic Recommending System for Premedication in Reducing Recurrent Radiocontrast Media Hypersensitivity Reactions
por: Bae, Yun-Jeong, et al.
Publicado: (2013)

Hypersensitivity reactions to iodinated radiocontrast media: Cluster analysis reveals distinct clinical phenotypes()
por: Srisuwatchari, Witchaya, et al.
Publicado: (2022)

The Pathophysiology and the Management of Radiocontrast-Induced Nephropathy
por: Cho, Eunjung, et al.
Publicado: (2022)

Successful Desensitization to the Radiocontrast Material Iohexol (Omnipaque™)
por: Saad, Abeer, et al.
Publicado: (2022)

Darbepoetin alfa reduces cell death due to radiocontrast media in human renal proximal tubular cells
por: Andreucci, Michele, et al.
Publicado: (2021)

Incomplete Recovery from the Radiocontrast-Induced Dysregulated Cell Cycle, Adhesion, and Fibrogenesis in Renal Tubular Cells after Radiocontrast (Iohexol) Removal
por: Chen, Hsing-Yu, et al.
Publicado: (2023)

Direct coronary stenting in reducing radiation and radiocontrast consumption
por: Caluk, Jasmin, et al.
Publicado: (2010)

Systemic and renal hemodynamic effects of intra-arterial radiocontrast
por: Calzavacca, Paolo, et al.
Publicado: (2014)

Assessment of the Radio-contrast Media-Induced Self-Reported Adverse Drug Reactions in a Tertiary Care Hospital of North India: A Prospective Study
por: Singh, Pushpinder, et al.
Publicado: (2022)

Clearance and Safety of the Radiocontrast Medium Iopamidol in Peritoneal Dialysis Patients
por: Hatakeyama, Shingo, et al.
Publicado: (2011)

Role of Reactive Oxygen Species in Pathogenesis of Radiocontrast-Induced Nephropathy
por: Pisani, Antonio, et al.
Publicado: (2013)

Impact of Mannose-Binding Lectin Deficiency on Radiocontrast-Induced Renal Dysfunction
por: Osthoff, Michael, et al.
Publicado: (2013)

Intraductal Ultrasonography without Radiocontrast Cholangiogram in Patients with Extrahepatic Biliary Disease
por: Lim, Sung-Uk, et al.
Publicado: (2015)

Imaging articular cartilage in osteoarthritis using targeted peptide radiocontrast agents
por: Fowkes, Milan M., et al.
Publicado: (2022)

Radiocontrast-Diatrozate and Iopromide-Induced Severe Hypocalcemia Leading to Painful Tetanic and Severe Laryngeal Spasm: A Near Fatal Encounter
por: Mahajan, Janhavi, et al.
Publicado: (2022)

Resin from Virola oleifera Protects Against Radiocontrast-Induced Nephropathy in Mice
por: Bôa, Igor Santos Fonte, et al.
Publicado: (2015)

Systemic hypersensitivity reaction to Omnipaque radiocontrast medium: a case of mini‐DRESS
por: George, Christina, et al.
Publicado: (2016)

Does Orally-Administered Radiocontrast Impair Ultrasound Image Quality in Pediatric Patients?
por: Patel, Amit, et al.
Publicado: (2020)

A Delayed, Unusual Non-Cardiogenic Pulmonary Edema after Intravascular Administration of Non-Ionic, Low Osmolar Radiocontrast Media for Coronary Angiography
por: Kang, Min-Ho, et al.
Publicado: (2013)

Applications and Diagnostic Potential of Dried Blood Spots
por: Gupta, Kapil, et al.
Publicado: (2018)

Radiocontrast Agent Diatrizoic Acid Induces Mitophagy and Oxidative Stress via Calcium Dysregulation
por: Ward, Dakota B., et al.
Publicado: (2019)

Comparison of serum creatinine and spot urine interleukin-18 levels following radiocontrast administration
por: Turkmen, F., et al.
Publicado: (2012)

MON-059 Acute Hyponatremia Following Computed Tomography Radiocontrast in a Pediatric Patient
por: Chiu, Harvey Kenn, et al.
Publicado: (2020)

The role of nuclear factor erythroid-2-related factor 2 expression in radiocontrast-induced nephropathy
por: Kim, Ji Eun, et al.
Publicado: (2019)

Acute Onset of Bullous Skin Rash and Acute Kidney Injury after Exposure to Radiocontrast: Sweet’s Syndrome
por: Abdelnabi, Mahmoud, et al.
Publicado: (2023)

Intradetrusor botulinum toxin type A in refractory overactive bladder: A potential future treatment
por: Mahajan, Rajiv, et al.
Publicado: (2011)

Conceptualizing Problem-Based Learning: An Overview
por: Virk, Amrit, et al.
Publicado: (2022)

Augmentation of Electrocardiographic QRS R-Amplitude Precedes Radiocontrast-Induced Hypotension during Mobile Computed Tomography Scanning
por: Kwon, Hye-Mee, et al.
Publicado: (2019)

A new update for radiocontrast-induced nephropathy aggravated with glycerol in rats: the protective potential of epigallocatechin-3-gallate
por: Palabiyik, Saziye Sezin, et al.
Publicado: (2017)

Safety concerns to application of graphene compounds in pharmacy and medicine
por: Mogharabi, Mehdi, et al.
Publicado: (2014)

Onasemnogene Abeparvovec for Spinal Muscular Atrophy: The Costlier Drug Ever
por: Mahajan, Rajiv
Publicado: (2019)

Prucalopride: A Recently Approved Drug by the Food and Drug Administration for Chronic Idiopathic Constipation
por: Mahajan, Rajiv
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o24e0nk3r4413spogbrnckbtuu